Randall Moreadith Age X Therapeutics, Inc. (AGE) insider trading activity

AGE Quotes by TradingView

Randall Moreadith is Chief Scientific Officer of AgeX Therapeutics, Inc.. Currently has a direct ownership of 0 shares of AGE, which is worth approximately $0. The most recent transaction as insider was on Aug 20, 2025, when has been sold 2,077 shares (Common Stock) at a price of $5.1 per share, resulting in proceeds of $10,592. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 0
n/a 3M change
n/a 12M change
Total Value Held $0

Randall Moreadith Transaction History

Date Transaction Value Shares Traded Shares Held Form
Aug 20 2025
SELL
Open market or private sale
$10,592 $5.1 p/Share
2,077 Reduced 100.0%
0 Common Stock
Aug 20 2025
BUY
Exercise of conversion of derivative security
$124 $0.06 p/Share
2,077 Added 50.0%
2,077 Common Stock
Aug 18 2025
SELL
Open market or private sale
$11,691 $5.25 p/Share
2,227 Reduced 100.0%
0 Common Stock
Aug 18 2025
BUY
Exercise of conversion of derivative security
$133 $0.06 p/Share
2,227 Added 50.0%
2,227 Common Stock
Aug 12 2025
SELL
Open market or private sale
$28,875 $5.25 p/Share
5,500 Reduced 100.0%
0 Common Stock
Aug 12 2025
BUY
Exercise of conversion of derivative security
$330 $0.06 p/Share
5,500 Added 50.0%
5,500 Common Stock
Aug 04 2025
SELL
Open market or private sale
$28,435 $5.17 p/Share
5,500 Reduced 100.0%
0 Common Stock
Aug 04 2025
BUY
Exercise of conversion of derivative security
$330 $0.06 p/Share
5,500 Added 50.0%
5,500 Common Stock
Jul 29 2025
SELL
Open market or private sale
$27,274 $6.5 p/Share
4,196 Reduced 100.0%
0 Common Stock
Jul 29 2025
BUY
Exercise of conversion of derivative security
$251 $0.06 p/Share
4,196 Added 50.0%
4,196 Common Stock
Jul 28 2025
SELL
Open market or private sale
$38,285 $5.89 p/Share
6,500 Reduced 100.0%
0 Common Stock
Jul 28 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Jul 21 2025
SELL
Open market or private sale
$34,710 $5.34 p/Share
6,500 Reduced 100.0%
0 Common Stock
Jul 21 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Jul 14 2025
SELL
Open market or private sale
$32,565 $5.01 p/Share
6,500 Reduced 100.0%
0 Common Stock
Jul 14 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Jul 07 2025
SELL
Open market or private sale
$36,855 $5.67 p/Share
6,500 Reduced 100.0%
0 Common Stock
Jul 07 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
Jun 30 2025
SELL
Open market or private sale
$37,570 $5.78 p/Share
6,500 Reduced 100.0%
0 Common Stock
Jun 30 2025
BUY
Exercise of conversion of derivative security
$390 $0.06 p/Share
6,500 Added 50.0%
6,500 Common Stock
RM

Randall Moreadith

Chief Scientific Officer
Huntsville, AL

Track Institutional and Insider Activities on AGE

Follow AgeX Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells AGE shares.

Notify only if

Insider Trading

Get notified when an Age X Therapeutics, Inc. insider buys or sells AGE shares.

Notify only if

News

Receive news related to AgeX Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on AGE